KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

93 hedge funds and large institutions have $459M invested in KalVista Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 22 reducing their positions, and 22 closing their positions.

Holders
93
Holders Change
-8
Holders Change %
-7.92%
% of All Funds
1.36%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
14
Increased
46
Reduced
22
Closed
22
Calls
$21.3M
Puts
$11.3M
Net Calls
+$10.1M
Net Calls Change
+$3.39M

Top Buyers

1
VA
1
VR Adviser
New York
$50.1M
2
Morgan Stanley
2
Morgan Stanley
New York
$11.1M
3
BlackRock
3
BlackRock
New York
$27.5M
4
SC
4
Stempoint Capital
New York
$5.18M
5
FLSM
5
Frazier Life Sciences Management
California
$44.4M

Top Sellers

1
LGM
1
Logos Global Management
California
$0
2
MB
2
MPM BioImpact
Massachusetts
$0
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$8.64M
4
OM
4
Opaleye Management
Massachusetts
$1.84M
5
First Manhattan
5
First Manhattan
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.48M 202,522 +28,200 +16%
Two Sigma Investments
27
Two Sigma Investments
New York
$2.03M 165,759 +61,965 +60%
CM
28
Caption Management
Oklahoma
$2.02M 165,000 +37,134 +29%
OM
29
Opaleye Management
Massachusetts
$1.84M 150,000 -350,000 -70%
SG Americas Securities
30
SG Americas Securities
New York
$1.69M 137,817 +6,670 +5%
AA
31
AlphaCentric Advisors
Puerto Rico
$1.68M 137,000 +2,000 +1%
GTC
32
Ghost Tree Capital
New York
$1.59M 130,036 +30,036 +30%
AAA
33
Affinity Asset Advisors
New York
$1.54M 125,969 -152,323 -55%
SCM
34
Silverarc Capital Management
Massachusetts
$1.37M 111,734 -117,200 -51%
Connor, Clark & Lunn Investment Management (CC&L)
35
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.36M 110,922 +6,254 +6%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.23M 100,693 +16,384 +19%
Walleye Capital
37
Walleye Capital
New York
$1.2M 97,830 +39,452 +68%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$1.09M 88,763 -26,519 -23%
Goldman Sachs
39
Goldman Sachs
New York
$1.07M 87,099 -121,713 -58%
Charles Schwab
40
Charles Schwab
California
$986K 80,451 +15,297 +23%
Nuveen Asset Management
41
Nuveen Asset Management
Illinois
$871K 71,067 +10,115 +17%
AI
42
Atom Investors
Texas
$856K 69,844 +4,558 +7%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
43
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$631K 51,500 -88,700 -63%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$626K 51,100 -22,900 -31%
Fidelity Investments
45
Fidelity Investments
Massachusetts
$624K 50,970 -6,596 -11%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$556K 45,361 +3,466 +8%
Barclays
47
Barclays
United Kingdom
$521K 42,531 +38,316 +909%
Renaissance Technologies
48
Renaissance Technologies
New York
$518K 42,300 -26,800 -39%
CCIA
49
Campbell & Co Investment Adviser
Maryland
$507K 41,365 +41,365 New
BC
50
Birchview Capital
Vermont
$490K 40,000 – –
1
2
3 4 5